Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FD.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FD.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DV.7.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.7.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.7.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
DV.7.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
DV.7.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.7.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.7.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
DV.7.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCLORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCLENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCLENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCLNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCH.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCH.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XCH.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCTORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCTENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCTENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCTNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.86.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.86.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.86.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.86.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDD.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDD.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDD.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HW.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HW.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HW.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HW.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used